Micro-costing studies in the health and medical literature: protocol for a systematic review.
Micro-costing studies in the health and medical literature: protocol for a systematic review.
复制标题
DOI：
10.1186/2046-4053-3-47
复制
发表时间：
2014-05-21
影响因子：
3.7
通讯作者：
Ruger JP
中科院分区：
文献类型：
--
作者：
Xu X;Grossetta Nardini HK;Ruger JP
微观成本计算是一种成本估算方法，可以精确评估卫生干预措施的经济成本。它已被证明是特别有用的估计成本的新的干预措施，为干预措施的巨大差异提供者，并估计真正的成本卫生系统和社会。然而，现有的经济评价准则没有提供进行微额成本计算分析时使用的方法和技术的足够细节。因此，本研究的目的是回顾目前的文献对卫生和医疗干预措施，战略和计划的微成本研究，以评估微成本方法的变化和现有研究的质量。这将为目前进行和报告微额成本计算研究的做法提供信息，并使今后的方法更加标准化。我们将对当前关于卫生和医疗干预、战略和计划的微观成本研究文献进行系统回顾。使用严格设计的检索策略，我们将检索奥维德MEDLINE、EconLit、BIOSIS Previews、Embase、Scopus和国家卫生服务经济评价数据库（NHS EED），以识别相关英文文章。这些检索将通过对识别出的相关文章的参考文献进行审查来补充。评审小组的两名成员将使用标准化数据收集表独立提取有关每篇纳入文章的设计和特征的详细信息。将咨询第三位评审员以解决差异。我们将使用为卫生经济学研究的批判性评价而开发的检查表来评价纳入研究的质量和潜在偏倚风险。这一系统性审查将提供有用的信息，帮助将进行和报告研究中的微额成本计算研究的方法和技术标准化，这可以提高今后研究的质量和透明度，并加强结果的可比性和解释。从长远来看，这些努力将促进临床和卫生政策的资源分配决策。系统综述注册：PROSPERO CRD 42014007453。
Micro-costing is a cost estimation method that allows for precise assessment of the economic costs of health interventions. It has been demonstrated to be particularly useful for estimating the costs of new interventions, for interventions with large variability across providers, and for estimating the true costs to the health system and to society. However, existing guidelines for economic evaluations do not provide sufficient detail of the methods and techniques to use when conducting micro-costing analyses. Therefore, the purpose of this study is to review the current literature on micro-costing studies of health and medical interventions, strategies, and programs to assess the variation in micro-costing methodology and the quality of existing studies. This will inform current practice in conducting and reporting micro-costing studies and lead to greater standardization in methodology in the future. We will perform a systematic review of the current literature on micro-costing studies of health and medical interventions, strategies, and programs. Using rigorously designed search strategies, we will search Ovid MEDLINE, EconLit, BIOSIS Previews, Embase, Scopus, and the National Health Service Economic Evaluation Database (NHS EED) to identify relevant English-language articles. These searches will be supplemented by a review of the references of relevant articles identified. Two members of the review team will independently extract detailed information on the design and characteristics of each included article using a standardized data collection form. A third reviewer will be consulted to resolve discrepancies. We will use checklists that have been developed for critical appraisal of health economics studies to evaluate the quality and potential risk of bias of included studies. This systematic review will provide useful information to help standardize the methods and techniques for conducting and reporting micro-costing studies in research, which can improve the quality and transparency of future studies and enhance comparability and interpretation of findings. In the long run, these efforts will facilitate clinical and health policy decision-making about resource allocation. Systematic review registration: PROSPERO CRD42014007453.